Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for EXHI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
April 30, 2026 0.00
January 31, 2026 0.00
October 31, 2025 0.00
July 31, 2025 0.00
April 30, 2025 0.00
January 31, 2025 0.00
October 31, 2024 0.00
July 31, 2024 0.00
April 30, 2024 0.00
January 31, 2024
October 31, 2023 0.00
July 31, 2023 0.00
April 30, 2023 -0.1003M
January 31, 2023
October 31, 2022 -0.0278M
July 31, 2022 -0.3436M
April 30, 2022 0.00
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
Date Value
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Xcelerate, Inc. -0.015M
Vivos Therapeutics, Inc. -0.416M
Hinge Health, Inc. 28.62M
Anika Therapeutics, Inc. -1.28M
Enovis Corp. -45.01M